Vyome Holdings (HIND) Cash from Investing Activities (2015 - 2024)
Vyome Holdings (HIND) posted quarterly Cash from Investing Activities of $1466.0 for Q4 2024, up 148.87% quarter-over-quarter from -$3000.0 in Q2 2023.
Vyome Holdings (HIND) Cash from Investing Activities (2015 - 2024) Analysis & Trends
Vyome Holdings' Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $1466.0 for Q4 2024.
- In Q4 2024, Cash from Investing Activities changed N/A year-over-year to $1466.0; the TTM figure through Dec 2024 stood at -$1534.0 (up 84.66% YoY), while the FY2024 annual figure was $315.0, up 103.15% from the prior year.
- Cash from Investing Activities for Q4 2024 stood at $1466.0, up from -$3000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $5.1 million in Q2 2021, with the low at -$3.1 million in Q4 2021.
- The 5-year median for Cash from Investing Activities is -$33000.0 (2022), against an average of -$42368.9.
- Peak annual rise in Cash from Investing Activities reached 24500.0% in 2020, while the deepest fall reached 1340.0% in 2020.
- Vyome Holdings' Cash from Investing Activities stood at -$2.2 million in 2020, then tumbled by 41.99% to -$3.1 million in 2021, then jumped by 97.42% to -$79000.0 in 2022, then soared by 96.2% to -$3000.0 in 2023, then soared by 148.87% to $1466.0 in 2024.
- Business Quant data shows HIND's Cash from Investing Activities at $1466.0 in Q4 2024, -$3000.0 in Q2 2023, and -$7000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,466.00 |
| Dec 31, 2024 | 1,466.00 |
| Jun 30, 2023 | -3,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Sep 30, 2022 | -33,000.00 |
| Sep 30, 2022 | -33,000.00 |
| Jun 30, 2022 | 18,000.00 |
| Jun 30, 2022 | 18,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | -3.07 Mn |
| Dec 31, 2021 | -3.07 Mn |
| Sep 30, 2021 | -89,000.00 |
| Sep 30, 2021 | -89,000.00 |
| Jun 30, 2021 | 5.13 Mn |
| Jun 30, 2021 | 5.13 Mn |